Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteogenomic-based discovery of minor histocompatibility antigens with suitable features for immunotherapy of hematologic cancers
Diana Paola Granados, Anja Rodenbrock, J-P Laverdure, et al.
Leukemia (2016) Vol. 30, Iss. 6, pp. 1344-1354
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

MHC class I–associated peptides derive from selective regions of the human genome
Hillary Pearson, Tariq Daouda, Diana Paola Granados, et al.
Journal of Clinical Investigation (2016) Vol. 126, Iss. 12, pp. 4690-4701
Open Access | Times Cited: 197
Clinical potential of mass spectrometry-based proteogenomics
Bing Zhang, Jeffrey R. Whiteaker, Andrew N. Hoofnagle, et al.
Nature Reviews Clinical Oncology (2018) Vol. 16, Iss. 4, pp. 256-268
Open Access | Times Cited: 174
Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease
Paul J. Martin, David Levine, Barry E. Storer, et al.
Blood (2016) Vol. 129, Iss. 6, pp. 791-798
Open Access | Times Cited: 106
Comparison of the MHC I Immunopeptidome Repertoire of B‐Cell Lymphoblasts Using Two Isolation Methods
Joël Lanoix, Chantal Durette, Mathieu Courcelles, et al.
PROTEOMICS (2018) Vol. 18, Iss. 12
Closed Access | Times Cited: 62
Extending the Comprehensiveness of Immunopeptidome Analyses Using Isobaric Peptide Labeling
Sibylle Pfammatter, Éric Bonneil, Joël Lanoix, et al.
Analytical Chemistry (2020) Vol. 92, Iss. 13, pp. 9194-9204
Closed Access | Times Cited: 53
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens
Kyra J. Fuchs, Marian van de Meent, M. Willy Honders, et al.
Blood (2024) Vol. 143, Iss. 18, pp. 1856-1872
Open Access | Times Cited: 6
Proteogenomics: From next-generation sequencing (NGS) and mass spectrometry-based proteomics to precision medicine
Mia Yang Ang, Teck Yew Low, Pey Yee Lee, et al.
Clinica Chimica Acta (2019) Vol. 498, pp. 38-46
Open Access | Times Cited: 50
T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
Valérie Janelle, Caroline Rulleau, Simon Del Testa, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 45
Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome
Theo Sturm, Benedikt Sautter, Tobias P. Wörner, et al.
Journal of Proteome Research (2020) Vol. 20, Iss. 1, pp. 289-304
Open Access | Times Cited: 41
BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
Maria Virginia Ruiz Cuevas, Marie‐Pierre Hardy, Jean‐David Larouche, et al.
Genome biology (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 15
Connecting Proteomics to Next‐Generation Sequencing: Proteogenomics and Its Current Applications in Biology
Teck Yew Low, M. Aiman Mohtar, Mia Yang Ang, et al.
PROTEOMICS (2018) Vol. 19, Iss. 10
Closed Access | Times Cited: 38
60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer Immunotherapy
Nicoletta Cieri, Katie Maurer, Catherine J. Wu
Cancer Research (2021) Vol. 81, Iss. 17, pp. 4373-4384
Open Access | Times Cited: 31
T-Cell Dysfunction as a Limitation of Adoptive Immunotherapy: Current Concepts and Mitigation Strategies
Valérie Janelle, Jean‐Sébastien Delisle
Cancers (2021) Vol. 13, Iss. 4, pp. 598-598
Open Access | Times Cited: 29
The HLA Ligand Atlas - A resource of natural HLA ligands presented on benign tissues
Ana Marcu, Leon Bichmann, Lèon Kuchenbecker, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2019)
Open Access | Times Cited: 32
IDENTIFICATION OF MHC PEPTIDES USING MASS SPECTROMETRY FOR NEOANTIGEN DISCOVERY AND CANCER VACCINE DEVELOPMENT
Rui Chen, Kelly M. Fulton, Susan M. Twine, et al.
Mass Spectrometry Reviews (2019) Vol. 40, Iss. 2, pp. 110-125
Closed Access | Times Cited: 31
Minor Histocompatibility Antigen-Specific T Cells
Corinne Summers, Vipul Sheth, Marie Bleakley
Frontiers in Pediatrics (2020) Vol. 8
Open Access | Times Cited: 28
Cellular therapy approaches harnessing the power of the immune system for personalized cancer treatment
Jean-Philippe Bastien, Annabelle Minguy, Vibhuti P. Davé, et al.
Seminars in Immunology (2019) Vol. 42, pp. 101306-101306
Open Access | Times Cited: 23
Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell Surface
Helena M. Bijen, Cesare Hassan, Michel G.D. Kester, et al.
PROTEOMICS (2017) Vol. 18, Iss. 12
Closed Access | Times Cited: 22
Acute Myeloid Leukemia: From Biology to Clinical Practices Through Development and Pre-Clinical Therapeutics
Xavier Roussel, Étienne Daguindau, Ana Berceanu, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 18
Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation
Jukka Partanen, Kati Hyvärinen, Heike Bickeböller, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 16
In Silico Analysis of the Minor Histocompatibility Antigen Landscape Based on the 1000 Genomes Project
Н. А. Быкова, Dmitry B. Malko, Grigory A. Efimov
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 18
Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT
Jarmo Ritari, Kati Hyvärinen, Satu Koskela, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 12
Personal tumor antigens in blood malignancies: genomics-directed identification and targeting
Livius Penter, Catherine J. Wu
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1595-1607
Open Access | Times Cited: 12
MAPDP: A Cloud-Based Computational Platform for Immunopeptidomics Analyses
Mathieu Courcelles, Chantal Durette, Tariq Daouda, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 4, pp. 1873-1881
Closed Access | Times Cited: 12
Minor histocompatibility antigens to predict, monitor or manipulate GvL and GvHD after allogeneic hematopoietic cell transplantation
Kyra J. Fuchs, J.H. Frederik Falkenburg, Marieke Griffioen
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 2, pp. 101555-101555
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top